STXS
HealthcareStereotaxis, Inc.
$2.36
+$0.04 (+1.72%)
Jan 5, 2026
Price History (1Y)
Analysis
Stereotaxis, Inc. is a healthcare company specializing in medical instruments and supplies, with a market capitalization of $220.25 million. The firm operates within the larger sector of Healthcare and has a relatively small workforce of 139 employees. Its revenue over the past four quarters amounts to $30.07 million. The financial health of Stereotaxis is marked by significant losses, as indicated by net income and EBITDA figures of -$24,904,000 and -$18,876,000 respectively. The company's gross margin stands at 53.1%, while its operating and profit margins are -69.7% and -78.6%. Returns on equity and assets are substantial losses, with ROE and ROA values of -170.2% and -26.4% respectively. The balance sheet shows a relatively modest debt level of $5.58 million against cash reserves of $10.51 million. Valuation metrics for Stereotaxis include a forward P/E ratio of -12.76, price to book value of 34.20, and price to sales ratio of 7.32. The company's revenue growth over the past year is reported at -18.8%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Visit website →Key Statistics
- Market Cap
- $220.25M
- P/E Ratio
- N/A
- 52-Week High
- $3.59
- 52-Week Low
- $1.54
- Avg Volume
- 542.06K
- Beta
- 1.44
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- ASE
- Country
- United States
- Employees
- 139